Add Yahoo as a preferred source to see more of our stories on Google. Illustration: Cat O'Neil/The Guardian (Illustration: Cat O'Neil/The Guardian) I first took beta blockers two years ago, when I was ...

Add Yahoo as a preferred source to see more of our stories on Google. A large new study conducted in Spain and Italy found that beta blockers, drugs often used to slow the heart rate and lower blood ...

Scientists have long suspected that stress hormones help fuel the spread of cancer. Now, new research has uncovered how a single gene may switch this process on and off in one of the most aggressive ...

Beta-blockers may fight the progression of triple-negative breast cancer, researchers have found Getty Beta blockers — a commonly prescribed blood pressure medication — may be useful in stopping the ...

Beta-blocker use is associated with a 34% reduction of onset in premanifest Huntington disease (preHD) and slower progression in early motor-manifest Huntington disease (mmHD), new research shows. In ...

Beta blockers are quickly becoming the hot new drug to combat anxiety. The medication, also known as propranolol, was approved by the U.S. Food and Drug Administration in 1967 for the treatment of ...

Imagine someone you care about suddenly experiencing chest pain, turning pale, and breathing heavily. These are some of the symptoms of a heart attack. Subscribe to our newsletter for the latest ...

A common heart attack pill may not be helpful for some heart conditions, according to new research. Bibek Raj Giri/Getty Images Beta-blockers are a common group of medications that help manage several ...

A major analysis led by the Centro Nacional de Investigaciones Cardiovasculares (CNIC), in collaboration with international institutions, has pooled data from 17,801 myocardial infarction survivors ...

Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...

The excess risk in women was mainly due to increased mortality and was most evident among those with preserved LVEF and those receiving higher doses of beta-blockers. (HealthDay News) — For women with ...